Receive case studies from MSD, Sanofi, GSK and more at European Pharmaceutical Pricing & Reimbursement

Top Quote SMi's European Pharmaceutical Pricing & Reimbursement conference, taking place on 5-6 October 2015 in London, will feature an array of case studies from pharma companies including MSD, Sanofi, GSK and more. End Quote
  • (1888PressRelease) July 23, 2015 - SMi's 21st annual European Pharmaceutical Pricing & Reimbursement conference will provide the ideal platform for payers and other decision makers from both public and private organisations, to benchmark with peers internationally and provide pharmaceutical companies with an invaluable insight into the decision making processes and approaches of vital stakeholders. The programme will help further your understanding and enable you to develop best practice approaches to complex market access challenges, with the ultimate goal of encouraging innovation and improving patient access to novel and powerful medications though case studies presented by GSK, Sanofi, MSD and more who will be presenting at the two-day conference.

    The Impact of Biosimilars and Orphan Drugs
    The Impact of Biosimilars of the Market
    Analysing the characteristics of biosimilars and the development of the EU's biosimilars market
    Exploring the likely impact of biosimilars on future pharmaceutical budgets based on different scenarios and models
    Identifying opportunities and challenges for industry, patients and payers, as well as appropriate pricing and reimbursement options - sustainable competition as a realistic option?
    Alexander Roediger, Director of European Union Affairs, MSD

    Purchasing Mechanisms and Working with Payers
    Tiered Pricing
    Increasing market access through the development of Tiered pricing
    Understanding new mechanisms to accessing a challenging market
    Developing socioeconomic methodologies to increase medication access
    Ken Walsh, Head of Emerging Markets Pricing, GSK

    Case Studies in Reforms
    Market Access in Turkey: Risks and opportunities in the post Healthcare Transformation Era
    Overview of Turkish Market Access & Healthcare Environment
    Basics of the Turkish Pricing & Reimbursement System
    Changing dynamics of the reimbursement system: Alternative models
    Government's mid-long term vision on pharmaceutical industry
    Toros Sahin, Head of Market Access & Health Economics, Sanofi

    To view the full speaker line-up and conference programme, visit http://www.pharmaceuticalpricing.co.uk/1888pressrelease

    Plus, don't miss the half-day interactive post-conference workshop:
    HTA Uncovered
    Led by Anke Van Engen, Principal - Advisory Services & Janice Haigh, Practice Leader Market Access, Quintiles
    8.30 - 12.30 | 7th October 2015, Holiday Inn Regents Park, London, UK

    ###
space
space
  • FB Icon Twitter Icon In-Icon
Contact Information
  • Vinh Trinh
  • Smi Group
  • Unit 122/124 Great Guildford Business Square, 30 Great Guildford Street, London
  • SE1 0BS
  • Voice: 44 (0) 20 7827 6140
  • Visit our Site